MedTrace Logo

Evaluation of the Short Message Service Effectiveness in the Screening Invitation Strategy for Breast Cancer (USIMaPI)

NCT03000920 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12000

Last updated 2019-07-18

No results posted yet for this study

Summary

Each year in France, breast cancer affects about 48,000 women and is the first cause of cancer death in women with 11,900 deaths estimated.

Since 2004, there is a national organized breast cancer screening (OBCS) programme for asymptomatic women aged 50-74 and with a medium-risk. Every two years, the local cancer screening department sends a personalized invitation mail to eligible women to perform a mammogram and a breast clinical examination. One to two reminder mails are sent to women who have not done the screening after an initial invitation. Despite this programme, almost 47% of women in France do not participate to organized breast cancer screening.

The Short Message Service (SMS) is an innovative communication tool in the field of health, immediate, reliable delivery, low cost and ecological. The use of SMS could be an innovative, low-cost, personalized and ecological way to support the OBCS invitation strategy.

The overall objective of this study is to preserve or even better increase participation in organized breast cancer screening while decreasing the associated costs by including SMS in our screening invitation procedure.

Two SMS interventions will be tested which will correspond to different phases of the OBCS invitation procedure. This sequence of interventions leads us to perform three interlinked trials: a trial of superiority for the first phase (intervention 1: sending an SMS a few days before the initial mail invitation), then two non-inferiority trials for the second phase ( two trials=one for each context of phase 1 \_ intervention 2: sending an SMS in place of the first postal reminder).

Conditions

Interventions

OTHER

SMS before invitation

A couple of days before the invitation letter, an SMS will be sent to announce the arrival of the invitation letter to the mammogram

OTHER

SMS Reminder 1

If it is necessary for the women to have a reminder 1, the usual mail will be replaced by an SMS.

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • ken HAGUENOER, Dr · Centre de Coordination des Dépistages des Cancers, CHRU de Tours

  • Somany SENGCHANH, Dr · Centre de Coordination des Dépistages des Cancers, CHRU de Tours

  • Julie Boyard · Centre de Coordination des Dépistages des Cancers, CHRU de Tours

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-02
Primary Completion
2018-12-01
Completion
2019-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03000920 on ClinicalTrials.gov